Impact of Increasing BMI on the Success of Neuraxial Blocks in Class III Obese Parturients

January 25, 2026 updated by: Mariah Arif

Evaluating the Impact of Increasing BMI on the Success of Neuraxial Blocks in Class III Obese Parturients: A Retrospective Cohort Study

This study seeks to compare the success rates, feto-maternal outcomes, and complications associated with different neuraxial blocks in Class III obese parturient undergoing cesarean section

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This was a retrospective cohort study. The data was obtained from electronic medical records of the eligible participants.

Study Type

Observational

Enrollment (Actual)

1917

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Qatar
      • Doha, Qatar
        • Women's Wellness and Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Class III Obese parturients undergoing C-section under neuraxial blocks in the operating rooms of Women's Wellness and Research Center from 1 January 2025 to 1 December 2024.

Description

Inclusion Criteria:

  • Age > or equal to 18 years
  • BMI ≥ 45 kg/m²
  • Gestational age ≥ 28 weeks

Exclusion Criteria:

  • Age < 18 years
  • BMI < 45 kg/m²
  • History of venous thromboembolism or arterial disease (e.g., DVT, PE, angina, MI, or stroke)
  • Severe active lung, cardiovascular, renal, or liver disorders; autoimmune disease; or hemoglobinopathies
  • Hereditary or acquired thrombophilia (e.g., Factor V Leiden mutation or antithrombin deficiency)
  • In utero fetal demise (IUFD)
  • Failed operative vaginal delivery
  • Cesarean for the second twin or multiple pregnancies (triplets or higher)
  • IVF pregnancy
  • Intraoperative bleeding>1500mL
  • Emergency cesarean section (Category I)
  • Presence of large uterine fibroid ≥10 cm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Class III obese parturient
Class III obese parturient undergoing cesarean section under neuraxial block
Procedure: Neuraxial anesthesia
Single-shot spinal anesthesia
Procedure: Neuraxial anesthesia
Epidural anesthesia
Procedure: Neuraxial anesthesia
Combined spinal-epidural anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Failed neuraxial block
Time Frame: From onset of block until surgery completion
Determine the occurrence of the conversion to general anesthesia
From onset of block until surgery completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal adverse events
Time Frame: From onset of blockade until surgery completion
Determine the incidence of maternal hypotension, bradycardia, high-spinal (above T1 level), level of blockade higher than T4, post-dural puncture headache
From onset of blockade until surgery completion
Fetal outcomes
Time Frame: At one and five minutes after birth
Apgar score
At one and five minutes after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mariah Arif

Investigators

  • Principal Investigator: Ayten Saracoglu, University of Florida, UF Health, Jacksonville, FL 32209, USA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2025

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

January 16, 2026

First Submitted That Met QC Criteria

January 16, 2026

First Posted (Actual)

January 26, 2026

Study Record Updates

Last Update Posted (Actual)

January 27, 2026

Last Update Submitted That Met QC Criteria

January 25, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MRC-01-24-905

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuraxial Blocks

Clinical Trials on Neuraxial anesthesia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe